Cheil Bio Co

Cheil Bio Co Current Liabilities

Delisted·Feb 25, 2026

Current Liabilities of Cheil Bio Co (052670.KQ) as of Nov 17, 2026.

Current Liabilities

-KRW

Last updated:

Current Liabilities of Cheil Bio Co is 2026 - KRW. Current Liabilities of Cheil Bio Co was 2025 2.13 B KRW. It decreases by % lower compared to the previous year.

The Cheil Bio Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2016
3.78 B KRW
Jan 1, 2017
2.41 B KRW
Jan 1, 2018
2.59 B KRW
Jan 1, 2019
2.86 B KRW
Jan 1, 2020
4.39 B KRW
Jan 1, 2021
6.20 M KRW
Jan 1, 2022
16.99 M KRW
Jan 1, 2023
2.13 B KRW
The Cheil Bio Co Current Liabilities history
YEARCurrent LiabilitiesYoY
2.13 BKRW+12,436.82%
16.99 MKRW+174.03%
6.20 MKRW-99.86%
4.39 BKRW+53.14%
2.86 BKRW+10.60%
2.59 BKRW+7.40%
2.41 BKRW-36.23%
3.78 BKRW-29.80%
5.39 BKRW+10.81%
4.86 BKRW-16.88%
5.85 BKRW+0.86%
5.80 BKRW+87.79%
3.09 BKRW+72.65%
1.79 BKRW+215.34%
567.00 MKRW-25.20%
758.00 MKRW+3.98%
729.00 MKRW-13.63%
844.00 MKRW-1.17%
854.00 MKRW+1.67%
840.00 MKRW-10.26%
936.00 MKRW-14.52%
1.10 BKRW-64.26%
3.06 BKRW+2.89%
2.98 BKRW-22.06%
3.82 BKRW-3.12%
3.94 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

On Eulerpool you can find the complete historical development of Current Liabilities Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cheil Bio Co

All Key Metrics — Cheil Bio Co